Literature DB >> 25303858

A nucleoprotein-enriched diet suppresses dopaminergic neuronal cell loss and motor deficit in mice with MPTP-induced Parkinson's disease.

Keisuke Kiriyama1, Hirokazu Ohtaki, Natsuki Kobayashi, Norimitsu Murai, Minako Matsumoto, Shun Sasaki, Chika Sawa, Kazue Satoh, Masaji Matsunaga, Seiji Shioda.   

Abstract

Parkinson's disease (PD) is an obstinate progressive neurodegenerative disease and characterized by locomotor impairment and dopaminergic neuronal degeneration in the substantia nigra pars compacta (SNc). We examined in here the dietary effect of nucleoprotein (NP) extracted from salmon soft roe on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-injected PD-like mice model to prevent the symptom as an alternative medicine. Male C57/BL6 mice were given either an artificially modified NP-free diet (NF) or NF supplied with 1.2% NP for 1 week. Then, mice were injected intraperitoneally four times with 20 mg/kg MPTP. Seven days later, locomotor activity was examined, and the brains were immunostained with tyrosine hydroxylase (TH) and Iba1 antibodies. Moreover, in situ detection of superoxide anion (O2(-)) and gene expression of mitochondrial electron transfer chain gene, Cox8b was evaluated in midbrains. NP-fed animals showed significantly reduced locomotor impairment and an increased number of TH-positive cells in the SNc compared with NF animals. The NP-fed animals also showed reduced lower levels of O2(-) and up-regulation of Cox8b levels and Iba1 immunoreactivity, suggesting that inflammation and oxidative stress were suppressed and mitochondrial impairment was relieved in these animals. Supplementation of the diet with NP may serve as a useful preventive measure to slow the onset of PD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25303858     DOI: 10.1007/s12031-014-0432-2

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  25 in total

1.  Dietary nucleic acids promote a shift in Th1/Th2 balance toward Th1-dominant immunity.

Authors:  N Sudo; Y Aiba; A Takaki; K Tanaka; X N Yu; N Oyama; Y Koga; C Kubo
Journal:  Clin Exp Allergy       Date:  2000-07       Impact factor: 5.018

2.  NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Authors:  Du-Chu Wu; Peter Teismann; Kim Tieu; Miquel Vila; Vernice Jackson-Lewis; Harry Ischiropoulos; Serge Przedborski
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

3.  Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation.

Authors:  Young C Chung; Sang R Kim; Ju-Young Park; Eun S Chung; Keun W Park; So Y Won; Eugene Bok; Minyoung Jin; Eun S Park; Sung-Hwa Yoon; Hyuk W Ko; Yoon-Seong Kim; Byung K Jin
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

Review 4.  Inflammation and adaptive immunity in Parkinson's disease.

Authors:  R Lee Mosley; Jessica A Hutter-Saunders; David K Stone; Howard E Gendelman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 5.  Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson's disease.

Authors:  Juliet M Taylor; Bevan S Main; Peter J Crack
Journal:  Neurochem Int       Date:  2013-01-04       Impact factor: 3.921

6.  Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine.

Authors:  V P Bindokas; J Jordán; C C Lee; R J Miller
Journal:  J Neurosci       Date:  1996-02-15       Impact factor: 6.167

7.  Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  T P Singer; N Castagnoli; R R Ramsay; A J Trevor
Journal:  J Neurochem       Date:  1987-07       Impact factor: 5.372

8.  Profiling changes in gait dynamics resulting from progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigrostriatal lesioning.

Authors:  Natalie R S Goldberg; Tom Hampton; Scott McCue; Ajit Kale; Charles K Meshul
Journal:  J Neurosci Res       Date:  2011-07-11       Impact factor: 4.164

9.  Protection of MPTP-induced neuroinflammation and neurodegeneration by Pycnogenol.

Authors:  Mohammad Moshahid Khan; Duraisamy Kempuraj; Ramasamy Thangavel; Asgar Zaheer
Journal:  Neurochem Int       Date:  2013-02-04       Impact factor: 3.921

10.  Increased mitochondrial DNA oxidative damage after transient middle cerebral artery occlusion in mice.

Authors:  Hirokazu Ohtaki; Takaaki Takeda; Kenji Dohi; Sachiko Yofu; Tomoya Nakamachi; Kazue Satoh; Yutaka Hiraizumi; Hideyo Miyaoka; Masaji Matsunaga; Seiji Shioda
Journal:  Neurosci Res       Date:  2007-04-19       Impact factor: 3.304

View more
  4 in total

1.  Neuroprotection of Fasting Mimicking Diet on MPTP-Induced Parkinson's Disease Mice via Gut Microbiota and Metabolites.

Authors:  Zhi-Lan Zhou; Xue-Bing Jia; Meng-Fei Sun; Ying-Li Zhu; Chen-Meng Qiao; Bo-Ping Zhang; Li-Ping Zhao; Qin Yang; Chun Cui; Xue Chen; Yan-Qin Shen
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

2.  Dental follicle cells show potential for treating Parkinson's disease through dopaminergic-neuronogenic differentiation.

Authors:  Fei Bi; Jie Xiong; Xue Han; Chao Yang; Xinghan Li; Guoqing Chen; Weihua Guo; Weidong Tian
Journal:  Hum Cell       Date:  2022-08-30       Impact factor: 4.374

Review 3.  Nutraceuticals in Parkinson's Disease.

Authors:  Liting Hang; Adeline Henry Basil; Kah-Leong Lim
Journal:  Neuromolecular Med       Date:  2016-05-04       Impact factor: 3.843

4.  Behavioral and omics analyses study on potential involvement of dipeptide balenine through supplementation in diet of senescence-accelerated mouse prone 8.

Authors:  Nobuhiro Wada; Satoru Yamanaka; Junko Shibato; Randeep Rakwal; Satoshi Hirako; Yuzuru Iizuka; Hyounju Kim; Akiyo Matsumoto; Ai Kimura; Fumiko Takenoya; Genta Yasunaga; Seiji Shioda
Journal:  Genom Data       Date:  2016-09-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.